FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32416611000001101: Losartan 25mg tablets (Kent Pharma (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1865381000001119 Losartan 25mg tablets (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1865391000001117 Losartan 25mg tablets (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Losartan 25mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) Is a Product containing precisely losartan potassium 25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) Has active ingredient Losartan potassium false Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) Has specific active ingredient Losartan potassium true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has AMP True Losartan 25mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start